Reaction Details Report a problem with these data
Target
Bromodomain-containing protein 3 [326-398]
Ligand
BDBM186322
Substrate
n/a
Meas. Tech.
FP Competitive Binding Assay (No.350)
Temperature
298.15±n/a K
Ki
406±192 nM
Comments
extracted
Citation
Wang, S; Ran, X; Zhao, Y; Yang, C; Liu, L; Bai, L; McEachern, D; Stuckey, J; Meagher, JL; Sun, D; Li, X; Zhou, B; Karatas, H; Luo, R; Chinnaiyan, A; Asangani, IA BET bromodomain inhibitors and therapeutic methods using the same US Patent US9675697 Publication Date 6/13/2017
More Info.:
Target
Name:
Bromodomain-containing protein 3 [326-398]
Synonyms:
BRD3 | BRD3_HUMAN | Bromodomain-containing protein 3 (BRD3)(BD2) | Bromodomain-containing protein 3 Bromo 2 domain(BRD3 BD2) | KIAA0043 | RING3L
Type:
n/a
Mol. Mass.:
8553.07
Organism:
Homo sapiens (Human)
Description:
BD2 (326-398 aa) of Q15059
Residue:
73
Sequence:
KHAAYAWPFYKPVDAEALELHDYHDIIKHPMDLSTVKRKMDGREYPDAQGFAADVRLMFSNCYKYNPPDHEVV
Inhibitor
Name:
BDBM186322
Synonyms:
US9675697, RX-39
Type:
n/a
Emp. Form.:
C18H16ClN3O2
Mol. Mass.:
341.792
SMILES:
CCc1noc(C)c1-c1cc2[nH]c3ccnc(Cl)c3c2cc1OC |(3.09,-3.38,;4.56,-3.87,;5.51,-3.02,;7.06,-3.35,;7.86,-1.97,;6.79,-.79,;7.05,.46,;5.36,-1.45,;3.99,-.65,;2.65,-1.4,;1.32,-.65,;.02,-1.4,;-1.28,-.65,;-2.62,-1.4,;-3.9,-.65,;-3.9,.87,;-2.62,1.63,;-2.64,3.17,;-1.28,.87,;1.32,.87,;2.65,1.63,;3.99,.87,;5.36,1.67,;5.36,2.94,)|